Edison MSB research report 7 June 2017
http://www.edisoninvestmentresearch.com/research/report/mesoblast15/preview/
Phase III HF trial end has potentially slipped by 12 months.
An NIH-funded 159-patient Phase IIb in end-stage HF is expected to be fully enrolled soon and the NIH may report data in Q417.
Kentgrove facility a real possibility.
Keeping an eye on MSB. Not time to buy back in yet.
GLTAH DYOR
Why the big drop?, page-29
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $2.433M | 2.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 72431 | 94.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 20225 | 5 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |